Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Real-World Effectiveness of Tirzepatide versus Semaglutide on HbA1c and Weight in Patients with Type 2 Diabetes.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: July 21, 2025
Post Hoc Analysis of SURPASS-1 to -5: Efficacy and Safety of Tirzepatide in Adults with Type 2 Diabetes are Independent of Baseline Characteristics.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: September 13, 2024
Glycemic and Cost Outcomes among Hispanic/Latino People with Type 2 Diabetes in the USA Initiating Dulaglutide versus Basal Insulin: a Real-World Study.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: December 13, 2023
Tirzepatide Improved Markers of Islet Cell Function and Insulin Sensitivity in People With T2D (SURPASS-2).
Journal: The Journal of clinical endocrinology and metabolism
Published: October 25, 2023
Tirzepatide in Hispanic/Latino Patients With Type 2 Diabetes: A Subgroup Analysis of the SURPASS Program.
Journal: The Journal of clinical endocrinology and metabolism
Published: June 28, 2023
Gender differences in cardiovascular risk, treatment, and outcomes: a post hoc analysis from the REWIND trial.
Journal: Scandinavian cardiovascular journal : SCJ
Published: February 01, 2023
HbA1c Reduction in Dulaglutide-Treated Patients Irrespective of Duration of Diabetes, Microvascular Disease, and BMI: A Post Hoc Analysis From the REWIND Trial.
Journal: Diabetes care
Published: June 01, 2021
Cardiovascular outcomes trials with glucagon-like peptide-1 receptor agonists: A comparison of study designs, populations and results.
Journal: Diabetes, obesity & metabolism
Published: May 27, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026